![Andrea Pederzolli](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andrea Pederzolli
Presidente presso
Laboratori Italiani Riuniti SpA
Profilo
Andrea Pederzolli is currently the Chairman at Laboratori Italiani Riuniti SpA since 2020.
Prior to this, he worked as a Fund Manager at Xyence Capital SGR from 2017 to 2021 and as a Director at Enterome SA.
Posizioni attive di Andrea Pederzolli
| Società | Posizione | Inizio |
|---|---|---|
Laboratori Italiani Riuniti SpA
 Laboratori Italiani Riuniti SpA Miscellaneous Commercial ServicesCommercial Services Operates as an analysis laboratory | Presidente | 01/02/2020 |
Precedenti posizioni note di Andrea Pederzolli
| Società | Posizione | Fine |
|---|---|---|
Xyence Capital SGR SpA
 Xyence Capital SGR SpA Investment ManagersFinance Xyence Capital invests in startup companies located in europe the United States and Italy. The firm targets companies operating in the field of electronic and health technology sector with particular focus in biotechnology and IT services. It provides equity for early to later stage as well as growth capital requirements with invests between EUR 0.5 to EUR 24 million. | Investitore di Private Equity | 01/05/2021 |
Enterome SA
 Enterome SA Pharmaceuticals: MajorHealth Technology Develops immunomodulatory drugs for treatment of cancer | Direttore/Membro del Consiglio | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
8
Relazioni di 1° grado
3
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
Xyence Capital SGR SpA
Xyence Capital SGR SpA Investment ManagersFinance Xyence Capital invests in startup companies located in europe the United States and Italy. The firm targets companies operating in the field of electronic and health technology sector with particular focus in biotechnology and IT services. It provides equity for early to later stage as well as growth capital requirements with invests between EUR 0.5 to EUR 24 million. | Finance |
Enterome SA
Enterome SA Pharmaceuticals: MajorHealth Technology Develops immunomodulatory drugs for treatment of cancer | Health Technology |
Laboratori Italiani Riuniti SpA
Laboratori Italiani Riuniti SpA Miscellaneous Commercial ServicesCommercial Services Operates as an analysis laboratory | Commercial Services |
